Mutation Information
Mutation Site
|
M204V |
Mutation Type
|
Amino acid level |
Gene/Protein/Region Type
|
RT |
Relevant Drug
|
lamivudine (LAM) |
Country
|
Thailand |
Literature Information
PubMed PMID
|
22860080
|
Disease
|
HBV-HIV coinfection
|
Published Year
|
2012 |
Journal
|
PloS one |
Title
|
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand. |
Author
|
Khamduang W,Gaudy-Graffin C,Ngo-Giang-Huong N,Jourdain G,Moreau A,Luekamlung N,Halue G,Buranawanitchakorn Y,Kunkongkapan S,Buranabanjasatean S,Lallemant M,Sirirungsi W,Goudeau A,Program for HIV Prevention and Treatment Study Group. |
Evidence
|
HBV breakthrough was observed only in HBeAg-positive patients and 6 of 7 patients presenting HBV breakthrough had the rtM204I/V mutations associated with 3TC resistance along with rtL180M and/or rtV173L.
|
|
|